- Home
- BNTC vs MTLS Comparison
BNTC vs MTLS Comparison
Compare BNTC & MTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTC
- MTLS
- Stock Information
- Founded
- BNTC 1995
- MTLS 1990
- Country
- BNTC United States
- MTLS Belgium
- Employees
- BNTC N/A
- MTLS N/A
- Industry
- BNTC Biotechnology: Pharmaceutical Preparations
- MTLS Computer Software: Prepackaged Software
- Sector
- BNTC Health Care
- MTLS Technology
- Exchange
- BNTC Nasdaq
- MTLS Nasdaq
- Market Cap
- BNTC 335.5M
- MTLS 349.7M
- IPO Year
- BNTC N/A
- MTLS 2014
- Fundamental
- Price
- BNTC $13.24
- MTLS $5.13
- Analyst Decision
- BNTC Strong Buy
- MTLS
- Analyst Count
- BNTC 5
- MTLS 0
- Target Price
- BNTC $26.00
- MTLS N/A
- AVG Volume (30 Days)
- BNTC 40.8K
- MTLS 127.2K
- Earning Date
- BNTC 09-25-2025
- MTLS 10-23-2025
- Dividend Yield
- BNTC N/A
- MTLS N/A
- EPS Growth
- BNTC N/A
- MTLS N/A
- EPS
- BNTC N/A
- MTLS 0.11
- Revenue
- BNTC N/A
- MTLS $311,850,851.00
- Revenue This Year
- BNTC N/A
- MTLS $2.98
- Revenue Next Year
- BNTC N/A
- MTLS $7.09
- P/E Ratio
- BNTC N/A
- MTLS $48.31
- Revenue Growth
- BNTC N/A
- MTLS 2.98
- 52 Week Low
- BNTC $8.06
- MTLS $3.93
- 52 Week High
- BNTC $17.15
- MTLS $9.69
- Technical
- Relative Strength Index (RSI)
- BNTC 59.72
- MTLS 47.90
- Support Level
- BNTC $12.57
- MTLS $5.01
- Resistance Level
- BNTC $13.33
- MTLS $5.32
- Average True Range (ATR)
- BNTC 0.60
- MTLS 0.18
- MACD
- BNTC 0.10
- MTLS 0.02
- Stochastic Oscillator
- BNTC 95.59
- MTLS 52.08
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.